possible increased risk of cleft lip and palate in babies exposed to Lamictal during pregnancy
The FDA is warning about a possible increased risk of cleft lip and palate in babies exposed to Lamictal during pregnancy.
This is due to a recent report from the North American Antiepileptic Drug (NAAED) Pregnancy Registry.
But the risk seems low...an increase from 0.05% to 0.3% in general to 0.9% in babies exposed to Lamictal (lamotrigine).
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote